Lisa Smits

Statistics

Publications

Citations

470

H-Index

Active since

2016

Affiliations

Radboud University Medical Center(Current)

Radboud University Nijmegen

Sanquin

Jeroen Bosch Ziekenhuis

University Medical Center Utrecht

Lisa Smits is an author at Radboud University Medical Center specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and pharmacotherapy.

ORCID

Publications per year

2016–2023

Publications

Clinical Outcomes Following a Switch from Remicade® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort Study

Lisa Smits, Lauranne Derikx, Dirk J. de Jong et al. · Journal of Crohn s and Colitis · 2016 · 140 citations

Pharmacy, Immunology, Pharmacotherapy +15

Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients

Michiel E. de Jong, Lisa Smits, B van Ruijven et al. · Journal of Crohn s and Colitis · 2020 · 75 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Long-Term Clinical Outcomes After Switching from Remicade® to Biosimilar CT-P13 in Inflammatory Bowel Disease

Lisa Smits, Anna Grelack, Lauranne Derikx et al. · Digestive Diseases and Sciences · 2017 · 68 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +10

TNF-α–induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade–driven IL-17A expression

Paulo C. M. Urbano, Raúl Aguirre‐Gamboa, Angel Ashikov et al. · Journal of Allergy and Clinical Immunology · 2017 · 40 citations

Life Sciences, Immunology, Molecular Biology +17

Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study

Lisa Smits, Aura A. J. van Esch, Lauranne Derikx et al. · Inflammatory Bowel Diseases · 2018 · 32 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

1–5 of 10